| Literature DB >> 30644586 |
Gretchen L Sacha1, Seth R Bauer1, Ishaq Lat2.
Abstract
Septic shock is a life-threatening disorder associated with high mortality rates requiring rapid identification and intervention. Vasoactive agents are often required to maintain goal hemodynamics and preserve tissue perfusion. However, guidance regarding the proper administration of adjunct agents for the management of septic shock is limited in patients who are refractory to norepinephrine. This review summarizes vasopressor agents and describes the nuanced application of these agents in patients with septic shock, specifically focusing on clinical scenarios with limited guidance including patients who are nonresponsive to first-line agents and individuals with mixed shock states, tachyarrhythmias, obesity, valvular abnormalities, or other comorbid conditions.Entities:
Keywords: angiotensin II; epinephrine; norepinephrine; phenylephrine; sepsis; septic shock; vasoactive agents; vasopressin
Mesh:
Substances:
Year: 2019 PMID: 30644586 DOI: 10.1002/phar.2220
Source DB: PubMed Journal: Pharmacotherapy ISSN: 0277-0008 Impact factor: 4.705